Kayne Anderson Capital Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,000
Closed -$527K 67
2023
Q4
$527K Hold
36,000
0.02% 69
2023
Q3
$519K Buy
+36,000
New +$561K 0.02% 75

Other funds holding BMEZ

Kayne Anderson Capital Advisors's BMEZ Position: Q1 2024 in Review

Kayne Anderson Capital Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 36,000 shares — an estimated $527K sold.

Kayne Anderson Capital Advisors first reported a position in BMEZ in Q3 2023 and held it in 2 quarters. The position peaked at $527K in Q4 2023. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Kayne Anderson Capital Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Kayne Anderson Capital Advisors sold 36,000 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $527K.
  • Kayne Anderson Capital Advisors first reported a position in BlackRock Health Sciences Trust II in Q3 2023 and held it in 2 quarters.
  • Kayne Anderson Capital Advisors's BlackRock Health Sciences Trust II position peaked at $527K in Q4 2023.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Kayne Anderson Capital Advisors's 13F filing for Q1 2024, filed 6 May 2024.